Clinical features and lipid metabolism genes as potential biomarkers in advanced lung cancer

[1] Sung H(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries Ca-a Cancer J Clin 71 209-249

[2] Ferlay J(2016)Lung Cancer in Never Smokers Adv Exp Med Biol 893 43-57

[3] Siegel RL(2016)COPD, emphysema and the onset of lung cancer A systematic review Cancer Letters 382 240-244

[4] Laversanne M(2008)Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers - A meta-analysis and evaluation of national brands Cancer 113 150-157

[5] Soerjomataram I(2011)Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening N Engl J Med 365 395-409

[6] Jemal A(2017)Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval Thorax 72 48-56

[7] Rivera GA(2016)Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial Lancet Oncology 17 907-916

[8] Wakelee H(2000)Prognostic factors for patients with small cell lung carcinoma - Analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years Cancer 89 523-533

[9] Mouronte-Roibas C(2017)Lung cancer: current therapies and new targeted treatments Lancet 389 299-311

[10] Leiro-Fernandez V(2017)Overexpression and proliferation dependence of acyl-CoA thioesterase 11 and 13 in lung adenocarcinoma Oncol Lett 14 3647-3656

[1] Sung H(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries Ca-a Cancer J Clin 71 209-249

[2] Ferlay J(2016)Lung Cancer in Never Smokers Adv Exp Med Biol 893 43-57

[3] Siegel RL(2016)COPD, emphysema and the onset of lung cancer A systematic review Cancer Letters 382 240-244

[4] Laversanne M(2008)Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers - A meta-analysis and evaluation of national brands Cancer 113 150-157

[5] Soerjomataram I(2011)Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening N Engl J Med 365 395-409

[6] Jemal A(2017)Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval Thorax 72 48-56

[7] Rivera GA(2016)Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial Lancet Oncology 17 907-916

[8] Wakelee H(2000)Prognostic factors for patients with small cell lung carcinoma - Analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years Cancer 89 523-533

[9] Mouronte-Roibas C(2017)Lung cancer: current therapies and new targeted treatments Lancet 389 299-311

[10] Leiro-Fernandez V(2017)Overexpression and proliferation dependence of acyl-CoA thioesterase 11 and 13 in lung adenocarcinoma Oncol Lett 14 3647-3656